A detailed history of Penobscot Investment Management Company, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Penobscot Investment Management Company, Inc. holds 24,967 shares of NVS stock, worth $2.42 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
24,967
Previous 24,767 0.81%
Holding current value
$2.42 Million
Previous $2.64 Million 8.92%
% of portfolio
0.27%
Previous 0.27%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$106.13 - $120.89 $21,226 - $24,178
200 Added 0.81%
24,967 $2.87 Million
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $579,951 - $672,673
6,265 Added 33.86%
24,767 $2.64 Million
Q1 2024

May 13, 2024

BUY
$95.27 - $108.47 $42,395 - $48,269
445 Added 2.46%
18,502 $1.79 Million
Q4 2023

Feb 05, 2024

BUY
$92.27 - $101.54 $321,930 - $354,273
3,489 Added 23.95%
18,057 $1.82 Million
Q3 2023

Nov 08, 2023

BUY
$94.73 - $105.13 $1.04 Million - $1.15 Million
10,943 Added 301.88%
14,568 $1.48 Million
Q2 2023

Aug 10, 2023

SELL
$92.52 - $104.91 $41,634 - $47,209
-450 Reduced 11.04%
3,625 $365,000
Q4 2021

Feb 11, 2022

SELL
$79.7 - $88.13 $7,970 - $8,813
-100 Reduced 2.4%
4,075 $356,000
Q3 2021

Nov 08, 2021

SELL
$81.78 - $95.14 $73,193 - $85,150
-895 Reduced 17.65%
4,175 $342,000
Q2 2021

Aug 09, 2021

SELL
$85.24 - $94.15 $234,410 - $258,912
-2,750 Reduced 35.17%
5,070 $463,000
Q1 2021

May 07, 2021

SELL
$83.5 - $98.47 $56,362 - $66,467
-675 Reduced 7.95%
7,820 $668,000
Q4 2020

Feb 08, 2021

SELL
$78.07 - $94.43 $46,841 - $56,658
-600 Reduced 6.6%
8,495 $802,000
Q3 2020

Nov 03, 2020

SELL
$82.14 - $91.0 $72,283 - $80,080
-880 Reduced 8.82%
9,095 $790,000
Q2 2020

Aug 04, 2020

SELL
$80.93 - $91.1 $12,139 - $13,665
-150 Reduced 1.48%
9,975 $871,000
Q1 2020

May 07, 2020

SELL
$70.67 - $99.01 $6,077 - $8,514
-86 Reduced 0.84%
10,125 $835,000
Q4 2019

Feb 04, 2020

SELL
$84.35 - $95.37 $27,835 - $31,472
-330 Reduced 3.13%
10,211 $967,000
Q3 2019

Nov 05, 2019

SELL
$85.54 - $94.26 $23,095 - $25,450
-270 Reduced 2.5%
10,541 $916,000
Q2 2019

Aug 02, 2019

SELL
$75.4 - $92.8 $7,540 - $9,280
-100 Reduced 0.92%
10,811 $988,000
Q1 2019

May 13, 2019

SELL
$75.32 - $86.15 $33,894 - $38,767
-450 Reduced 3.96%
10,911 $1.05 Million
Q4 2018

Feb 12, 2019

SELL
$73.66 - $82.02 $50,825 - $56,593
-690 Reduced 5.73%
11,361 $974,000
Q3 2018

Nov 01, 2018

SELL
$66.94 - $77.43 $31,796 - $36,779
-475 Reduced 3.79%
12,051 $1.04 Million
Q2 2018

Aug 07, 2018

SELL
$64.91 - $73.36 $173,244 - $195,797
-2,669 Reduced 17.56%
12,526 $946,000
Q1 2018

May 07, 2018

BUY
$70.39 - $84.15 $786,185 - $939,871
11,169 Added 277.42%
15,195 $1.23 Million
Q3 2017

Nov 02, 2017

BUY
$74.14 - $77.27 $298,487 - $311,089
4,026
4,026 $346,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Penobscot Investment Management Company, Inc. Portfolio

Follow Penobscot Investment Management Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penobscot Investment Management Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Penobscot Investment Management Company, Inc. with notifications on news.